Aveo shares drop with uncertainty of NDA submission for Fotivda

Aveo Pharmaceuticals Inc. (NASDAQ:AVEO) lost $1.07 (60%) to $0.70 Thursday after the company said it will not submit an NDA to FDA

Read the full 224 word article

How to gain access

Continue reading with a
two-week free trial.